2020-11-16T19:10:38-06:00 2019-12-31 061671819 PKF O'CONNOR DAVIES LLP 665 FIFTH AVENUE NEW YORK NY 10022 990 2019-01-01 133299366 AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE AMER 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO PRESIDENT/CEO 2125665555 2020-11-16 1 GARRETT M HIGGINS P00543209 2122862600 2020-11-13 68.175.34.111 2020-11-16 18:37:16 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 B29914CEB47F2C50F9800CDE5B5AE22990D509AB 2019 2021-01-29 14:40:06Z AATOD MARK W PARRINO 225 VARICK STREET 4TH FL NEW YORK NY 10014 1987572 0 X WWW.AATOD.ORG X 1984 NY TO ENHANCE THE QUALITY OF PATIENT CARE IN COMPREHENSIVE OPIOID TREATMENT PROGRAMS. 33 32 4 32 0 0 324967 311388 1723378 1667533 21 31 6598 8620 2054964 1987572 0 0 0 0 478936 492078 0 0 56945 1311315 1348683 1790251 1840761 264713 146811 612258 732008 199384 172323 412874 559685 THE AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE ("AATOD") WAS FOUNDED IN 1984 TO ENHANCE THE QUALITY OF PATIENT CARE IN TREATMENT PROGRAMS BY PROMOTING THE GROWTH AND DEVELOPMENT OF COMPREHENSIVE OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES. 0 0 983689 1104594 NATIONAL CONFERENCE- AATOD PRODUCES NATIONAL CONFERENCES ON AN EIGHTEEN MONTH CYCLE. THESE CONFERENCES PROVIDE AN OPPORTUNITY TO INTERESTED PARTIES TO LEARN ABOUT THE MOST CURRENT EVIDENCE BASED PRACTICES IN OUR FIELD. 386395 562939 RX OPIOID STUDY- TO BETTER UNDERSTAND THE IMPACT OF PRESCRIPTION OPIOID USE ON ADMISSIONS TO OPIOID TREATMENT PROGRAMS. SEVENTY FIVE TREATMENT PROGRAMS PROVIDE TREND ANALYSIS DATA. 104579 OTPS STUDY- TO INCREASE ACCESS TO THE TREATMENT OF OPIOID ADDICTION THROUGH OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES OF AMERICA. 1474663 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 4 1 0 0 0 0 0 0 0 0 0 0 0 0 X 33 32 0 0 0 0 1 0 0 1 1 0 0 1 1 0 0 0 0 1 0 0 NY X X MARK PARRINO 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO MPA PRESIDENT/CEO 40.00 X X 185000 0 18615 JANICE F KAUFFMAN FIRST V.P. 1.00 X X 0 0 0 ANN JAMIESON SECOND V.P. 1.00 X X 0 0 0 TINA BECKLEY SECRETARY 1.00 X X 0 0 0 MICHAEL RIZZI TREASURER 1.00 X X 0 0 0 RICHARD BILANGI DIRECTOR 1.00 X 0 0 0 HOLLY BROCE DIRECTOR 1.00 X 0 0 0 ROYE T BROWN DIRECTOR 1.00 X 0 0 0 SUSAN CASE DIRECTOR 1.00 X 0 0 0 BRIAN CRISSMAN DIRECTOR 1.00 X 0 0 0 CHERYL L GARDINE DIRECTOR 1.00 X 0 0 0 BRIAN GOODLETT DIRECTOR 1.00 X 0 0 0 GLORIA HANANIA DIRECTOR 1.00 X 0 0 0 KENNY HOUSE DIRECTOR 1.00 X 0 0 0 ASIF KHAN DIRECTOR 1.00 X 0 0 0 GENEVIEVE KING DIRECTOR 1.00 X 0 0 0 JASON KLETTER DIRECTOR 1.00 X 0 0 0 ERIN LACOURT DIRECTOR 1.00 X 0 0 0 ROBERT LAMBERT DIRECTOR 1.00 X 0 0 0 WENDY LOOKER DIRECTOR 1.00 X 0 0 0 CHRISTINE MARTIN DIRECTOR 1.00 X 0 0 0 BRIAN MCCARROLL DIRECTOR 1.00 X 0 0 0 JOSH NIRELLA DIRECTOR 1.00 X 0 0 0 VICTOR NEVAREZ DIRECTOR 1.00 X 0 0 0 STACEY PEARCE DIRECTOR 1.00 X 0 0 0 EVELYN REINHARDT DIRECTOR 1.00 X 0 0 0 MARGARET B RIZZO DIRECTOR 1.00 X 0 0 0 SHAREL ROGERS DIRECTOR 1.00 X 0 0 0 ALLEGRA SCHORR DIRECTOR 1.00 X 0 0 0 DINITA SMITH DIRECTOR 1.00 X 0 0 0 STEVEN SMITH DIRECTOR 1.00 X 0 0 0 NICK STAVROS DIRECTOR 1.00 X 0 0 0 KENNETH STOLLER MD DIRECTOR 1.00 X 0 0 0 JOANNA BAEZ DIRECTOR (LEFT IN 2019) 1.00 X 0 0 0 MOLLY CARNEY DIRECTOR (LEFT IN 2019) 1.00 X 0 0 0 BRETT LECHLEITNER DIRECTOR (LEFT IN 2019) 1.00 X 0 0 0 ARTURO VALDEZ DIRECTOR (LEFT IN 2019) 1.00 X 0 0 0 185000 0 18615 1 0 1 0 0 311388 311388 NATIONAL CONFERENCE 900099 1104594 1104594 RX OPIOID STUDY 900099 311969 311969 MEMBERSHIP DUES 900099 250970 250970 1667533 31 31 MISCELLANEOUS 900099 8620 8620 8620 1987572 1667533 0 8651 203615 104365 79839 19411 206811 106222 80874 19715 7554 3793 3041 720 45888 23039 18474 4375 28210 14164 11357 2689 82000 82000 37158 22783 10146 4229 7200 7200 61422 45955 13763 1704 12403 5769 5563 1071 118315 44655 73660 12651 11855 640 156 924436 913420 8857 2159 2572 1321 1006 245 4943 2539 1933 471 PROGRAM INCENTIVES 83670 83670 MISCELLANEOUS 1913 1913 1840761 1474663 309153 56945 366118 346598 346 346 107071 166583 55212 112265 6450 15734 24971 24971 0 0 77061 90482 612258 732008 56379 38117 16020 2700 25218 25207 101767 106299 199384 172323 X 335813 469203 77061 90482 412874 559685 612258 732008 146811 0 X X 0 1 X 1 0 X 239466 341419 97072 324967 311388 1314312 1649027 1735924 662824 1723378 1667533 7438686 1888493 2077343 759896 2048345 1978921 8752998 0 535194 546194 526379 322173 292093 2222033 535194 546194 526379 322173 292093 2222033 6530965 33 287 1 21 31 373 33 287 1 21 31 373 5479 1645 6598 8620 22342 1894005 2077630 761542 2054964 1987572 8775713 0.74420 0.67530 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2015 AMOUNT: $ 5,479. 2017 AMOUNT: $ 1,645. 2018 AMOUNT: $ 6,598. 2019 AMOUNT: $ 8,620. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5150 5150 0 19821 19821 0 0 RESTRICTED CASH 90482 90482 DEFERRED RENT 106299 106299 X 1987572 0 1987572 0 1987572 1840761 0 1840761 0 1840761 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2016. X X X 0 0 0 0 0 0 0 0 0 MARK W PARRINO MPA PRESIDENT/CEO 185000 0 0 0 0 0 8500 0 10115 0 203615 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION OFFERS STATE MEMBERSHIP TO ORGANIZATIONS IN THE MEDICATION ASSISTED TREATMENT FIELD. A. STATE AND COUNTRY ASSOCIATION MEMBERS (ASSOCIATIONS WITH A MINIMUM OF 3 PROVIDERS) EACH MEMBER IN THIS CLASS NOMINATES A BOD DIRECTOR TO REPRESENT THEM FOR 4 YEAR TERM B. MEMBERS AT LARGE (INDIVIDUALS WITH EXPERTISE) EACH MEMBER IN THIS CLASS HAS VOTING RIGHTS AT GENERAL MEMBERSHIP MEETINGS FOR 4 YEAR TERM. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE PRESIDENT, FISCAL MANAGER, THE TREASURER, AND FINANCE COMMITTEE BEFORE FILING. THE FINAL FORM 990 IS PROVIDED TO THE FULL BOARD OF DIRECTORS BEFORE E-FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, ACTING AS THE COMPENSATION COMMITTEE, CONDUCTS ANNUAL REVIEWS OF THE PRESIDENT'S PERFORMANCE AND COMPENSATION. EVERY THIRD YEAR THE EXECUTIVE COMMITTEE REVIEWS COMPARABILITY DATA AND SETS NEW COMPENSATION LEVELS TO BE REFLECTED IN THE PRESIDENT'S THREE YEAR CONTRACT. THE CONTRACT AS PROPOSED BY THE EXECUTIVE COMMITTEE IS THEN SUBMITTED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THIS PROCESS LAST OCCURED IN 2019. ALL DECISIONS WERE DOCUMENTED IN THE MINUTES OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, AATOD MAKES AVAILABLE TO THE PUBLIC ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS. FORM 990, PART XII, LINE 2C: AATOD HAS A FINANCE COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT AUDITOR. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.